Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancer

BACKGROUND: Patients with liver metastatic colorectal cancer (mCRC) often benefit from receiving (90)Y-microsphere radioembolization (RE) administered via the hepatic arteries. Prior to delivery of liver-directed radiation, standard laboratory tests may assist in improving outcome by identifying cor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Kennedy, Andrew S., Ball, David, Cohen, Steven J., Cohn, Michael, Coldwell, Douglas M., Drooz, Alain, Ehrenwald, Edward, Kanani, Samir, Moeslein, Fred M., Nutting, Charles W., Putnam, Samuel G., Rose, Steven C., Savin, Michael, Schirm, Sabine, Sharma, Navesh K., Wang, Eric
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334043/
https://ncbi.nlm.nih.gov/pubmed/28280611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.01.03
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars